Alterations in levels of intermediate-chained acylcarnitines associate with weight-gain following reestablishment of euthyroidism in Graves’ disease

Zurück zum Zitat G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, D. Panagiotakos, N. Tountas, T. Economopoulos, S.A. Raptis, Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J. Clin. Endocrinol. Metab. 93(6), 2413–2415 (2008)CrossRefPubMed G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, D. Panagiotakos, N. Tountas, T. Economopoulos, S.A. Raptis, Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. J. Clin. Endocrinol. Metab. 93(6), 2413–2415 (2008)CrossRefPubMed

Zurück zum Zitat R.L. Mynatt, E.A. Park, F.E. Thorngate, H.K. Das, G.A. Cook, Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem. Biophys. Res. Commun. 201(2), 932–937 (1994)CrossRefPubMed R.L. Mynatt, E.A. Park, F.E. Thorngate, H.K. Das, G.A. Cook, Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity. Biochem. Biophys. Res. Commun. 201(2), 932–937 (1994)CrossRefPubMed

Zurück zum Zitat M.S. Jansen, G.A. Cook, S. Song, E.A. Park, Thyroid hormone regulates carnitine palmitoyltransferase Ialpha gene expression through elements in the promoter and first intron. J. Biol. Chem. 275(45), 34989–34997 (2000)CrossRefPubMed M.S. Jansen, G.A. Cook, S. Song, E.A. Park, Thyroid hormone regulates carnitine palmitoyltransferase Ialpha gene expression through elements in the promoter and first intron. J. Biol. Chem. 275(45), 34989–34997 (2000)CrossRefPubMed

Zurück zum Zitat R.R. Ramsay, A. Arduini, The carnitine acyltransferases and their role in modulating Acyl-Coa pools. Arch. Biochem. Biophys. 302(2), 307–314 (1993)CrossRefPubMed R.R. Ramsay, A. Arduini, The carnitine acyltransferases and their role in modulating Acyl-Coa pools. Arch. Biochem. Biophys. 302(2), 307–314 (1993)CrossRefPubMed

Zurück zum Zitat C.L. Chng, A.Y. Lim, H.C. Tan, J.P. Kovalik, K.W. Tham, Y.M. Bee, W. Lim, S. Acharyya, O.F. Lai, M.F. Chong, P.M. Yen, Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in Graves’ disease. Thyroid 26(10), 1422–1430 (2016)CrossRefPubMed C.L. Chng, A.Y. Lim, H.C. Tan, J.P. Kovalik, K.W. Tham, Y.M. Bee, W. Lim, S. Acharyya, O.F. Lai, M.F. Chong, P.M. Yen, Physiological and metabolic changes during the transition from hyperthyroidism to euthyroidism in Graves’ disease. Thyroid 26(10), 1422–1430 (2016)CrossRefPubMed

Zurück zum Zitat M. Al-Majdoub, M. Lantz, P. Spegel, Treatment of Swedish patients with Graves’ hyperthyroidism is associated with changes in acylcarnitine levels. Thyroid 27(9), 1109–1117 (2017)CrossRefPubMed M. Al-Majdoub, M. Lantz, P. Spegel, Treatment of Swedish patients with Graves’ hyperthyroidism is associated with changes in acylcarnitine levels. Thyroid 27(9), 1109–1117 (2017)CrossRefPubMed

Zurück zum Zitat C.M. Girgis, B.L. Champion, J.R. Wall, Current concepts in graves’ disease. Ther. Adv. Endocrinol. Metab. 2(3), 135–144 (2011)CrossRefPubMedPubMedCentral C.M. Girgis, B.L. Champion, J.R. Wall, Current concepts in graves’ disease. Ther. Adv. Endocrinol. Metab. 2(3), 135–144 (2011)CrossRefPubMedPubMedCentral

Zurück zum Zitat S. Jansson, G. Berg, G. Lindstedt, A. Michanek, E. Nyström, Overweight - a common problme among women treated for hyperthydoidism. Postgrad. Med. J. 69, 107–111 (1993)CrossRefPubMedPubMedCentral S. Jansson, G. Berg, G. Lindstedt, A. Michanek, E. Nyström, Overweight - a common problme among women treated for hyperthydoidism. Postgrad. Med. J. 69, 107–111 (1993)CrossRefPubMedPubMedCentral

Zurück zum Zitat J. Dale, J. Daykin, R. Holder, M.C. Sheppard, J.A. Franklyn, Weight gain following treatment of hyperthyroidism. Clin. Endocrinol. 55(2), 233–239 (2001)CrossRef J. Dale, J. Daykin, R. Holder, M.C. Sheppard, J.A. Franklyn, Weight gain following treatment of hyperthyroidism. Clin. Endocrinol. 55(2), 233–239 (2001)CrossRef

Zurück zum Zitat M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, C. Margono, E.C. Mullany, S. Biryukov, C. Abbafati, S.F. Abera, J.P. Abraham, N.M. Abu-Rmeileh, T. Achoki, F.S. AlBuhairan, Z.A. Alemu, R. Alfonso, M.K. Ali, R. Ali, N.A. Guzman, W. Ammar, P. Anwari, A. Banerjee, S. Barquera, S. Basu, D.A. Bennett, Z. Bhutta, J. Blore, N. Cabral, I.C. Nonato, J.C. Chang, R. Chowdhury, K.J. Courville, M.H. Criqui, D.K. Cundiff, K.C. Dabhadkar, L. Dandona, A. Davis, A. Dayama, S.D. Dharmaratne, E.L. Ding, A.M. Durrani, A. Esteghamati, F. Farzadfar, D.F. Fay, V.L. Feigin, A. Flaxman, M.H. Forouzanfar, A. Goto, M.A. Green, R. Gupta, N. Hafezi-Nejad, G.J. Hankey, H.C. Harewood, R. Havmoeller, S. Hay, L. Hernandez, A. Husseini, B.T. Idrisov, N. Ikeda, F. Islami, E. Jahangir, S.K. Jassal, S.H. Jee, M. Jeffreys, J.B. Jonas, E.K. Kabagambe, S.E. Khalifa, A.P. Kengne, Y.S. Khader, Y.H. Khang, D. Kim, R.W. Kimokoti, J.M. Kinge, Y. Kokubo, S. Kosen, G. Kwan, T. Lai, M. Leinsalu, Y. Li, X. Liang, S. Liu, G. Logroscino, P.A. Lotufo, Y. Lu, J. Ma, N.K. Mainoo, G.A. Mensah, T.R. Merriman, A.H. Mokdad, J. Moschandreas, M. Naghavi, A. Naheed, D. Nand, K.M. Narayan, E.L. Nelson, M.L. Neuhouser, M.I. Nisar, T. Ohkubo, S.O. Oti, A. Pedroza, D. Prabhakaran, N. Roy, U. Sampson, H. Seo, S.G. Sepanlou, K. Shibuya, R. Shiri, I. Shiue, G.M. Singh, J.A. Singh, V. Skirbekk, N.J. Stapelberg, L. Sturua, B.L. Sykes, M. Tobias, B.X. Tran, L. Trasande, H. Toyoshima, S. van de Vijver, T.J. Vasankari, J.L. Veerman, G. Velasquez-Melendez, V.V. Vlassov, S.E. Vollset, T. Vos, C. Wang, X. Wang, E. Weiderpass, A. Werdecker, J.L. Wright, Y.C. Yang, H. Yatsuya, J. Yoon, S.J. Yoon, Y. Zhao, M. Zhou, S. Zhu, A.D. Lopez, C.J. Murray, E. Gakidou, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945), 766–781 (2014)CrossRefPubMedPubMedCentral M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, C. Margono, E.C. Mullany, S. Biryukov, C. Abbafati, S.F. Abera, J.P. Abraham, N.M. Abu-Rmeileh, T. Achoki, F.S. AlBuhairan, Z.A. Alemu, R. Alfonso, M.K. Ali, R. Ali, N.A. Guzman, W. Ammar, P. Anwari, A. Banerjee, S. Barquera, S. Basu, D.A. Bennett, Z. Bhutta, J. Blore, N. Cabral, I.C. Nonato, J.C. Chang, R. Chowdhury, K.J. Courville, M.H. Criqui, D.K. Cundiff, K.C. Dabhadkar, L. Dandona, A. Davis, A. Dayama, S.D. Dharmaratne, E.L. Ding, A.M. Durrani, A. Esteghamati, F. Farzadfar, D.F. Fay, V.L. Feigin, A. Flaxman, M.H. Forouzanfar, A. Goto, M.A. Green, R. Gupta, N. Hafezi-Nejad, G.J. Hankey, H.C. Harewood, R. Havmoeller, S. Hay, L. Hernandez, A. Husseini, B.T. Idrisov, N. Ikeda, F. Islami, E. Jahangir, S.K. Jassal, S.H. Jee, M. Jeffreys, J.B. Jonas, E.K. Kabagambe, S.E. Khalifa, A.P. Kengne, Y.S. Khader, Y.H. Khang, D. Kim, R.W. Kimokoti, J.M. Kinge, Y. Kokubo, S. Kosen, G. Kwan, T. Lai, M. Leinsalu, Y. Li, X. Liang, S. Liu, G. Logroscino, P.A. Lotufo, Y. Lu, J. Ma, N.K. Mainoo, G.A. Mensah, T.R. Merriman, A.H. Mokdad, J. Moschandreas, M. Naghavi, A. Naheed, D. Nand, K.M. Narayan, E.L. Nelson, M.L. Neuhouser, M.I. Nisar, T. Ohkubo, S.O. Oti, A. Pedroza, D. Prabhakaran, N. Roy, U. Sampson, H. Seo, S.G. Sepanlou, K. Shibuya, R. Shiri, I. Shiue, G.M. Singh, J.A. Singh, V. Skirbekk, N.J. Stapelberg, L. Sturua, B.L. Sykes, M. Tobias, B.X. Tran, L. Trasande, H. Toyoshima, S. van de Vijver, T.J. Vasankari, J.L. Veerman, G. Velasquez-Melendez, V.V. Vlassov, S.E. Vollset, T. Vos, C. Wang, X. Wang, E. Weiderpass, A. Werdecker, J.L. Wright, Y.C. Yang, H. Yatsuya, J. Yoon, S.J. Yoon, Y. Zhao, M. Zhou, S. Zhu, A.D. Lopez, C.J. Murray, E. Gakidou, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9945), 766–781 (2014)CrossRefPubMedPubMedCentral

Zurück zum Zitat M.G. Schooneman, A. Napolitano, S.M. Houten, G.K. Ambler, P.R. Murgatroyd, S.R. Miller, C.E. Hollak, C.Y. Tan, S. Virtue, A. Vidal-Puig, D.J. Nunez, M.R. Soeters, Assessment of plasma acylcarnitines before and after weight loss in obese subjects. Arch. Biochem. Biophys. 606, 73–80 (2016)CrossRefPubMed M.G. Schooneman, A. Napolitano, S.M. Houten, G.K. Ambler, P.R. Murgatroyd, S.R. Miller, C.E. Hollak, C.Y. Tan, S. Virtue, A. Vidal-Puig, D.J. Nunez, M.R. Soeters, Assessment of plasma acylcarnitines before and after weight loss in obese subjects. Arch. Biochem. Biophys. 606, 73–80 (2016)CrossRefPubMed

Zurück zum Zitat S.J. Mihalik, B.H. Goodpaster, D.E. Kelley, D.H. Chace, J. Vockley, F.G. Toledo, J.P. DeLany, Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18(9), 1695–1700 (2010)CrossRefPubMed S.J. Mihalik, B.H. Goodpaster, D.E. Kelley, D.H. Chace, J. Vockley, F.G. Toledo, J.P. DeLany, Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18(9), 1695–1700 (2010)CrossRefPubMed